Orodispersible Minitablets of Enalapril in Young Children With Heart Failure Due to Congenital Heart Disease
Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Paediatric clinical trial in 50 children, from newborn to less than 6 years of age, suffering
from heart failure due to congenital heart disease, to obtain paediatric pharmacokinetic and
pharmacodynamic data of enalapril and its active metabolite enalaprilat while treated for 8
weeks with enalapril in form of Orodispersible Minitablets (ODMTs), to describe the dose
exposure in this patient population.